Inovio to report first quarter 2025 financial results on may 13, 2025

Plymouth meeting, pa. , april 29, 2025 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-associated diseases, cancers, and infectious diseases, today announced that first quarter 2025 financial results will be released after the market close on may 13, 2025.
INO Ratings Summary
INO Quant Ranking